Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03337399 · ClinicalTrials.gov registry record · NA
Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer
A NA study of Lung Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 507
- Enrollment target
- 3
- Study locations
NCT03337399: Completed NA study of Lung Cancer, sponsored by Massachusetts General Hospital.
NCT03337399 is a NA study of Lung Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 507 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (46% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03337399, a NA study of Lung Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 507 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
Primary Outcome
Quality of life as measured by the Functional Assessment of Cancer Therapy-Lung Range 0-136 with higher scores indicating better quality of life
Conditions Studied
Interventions
- OTHER Stepped PC
- OTHER Early Integrated PC
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
North Carolina
- Duke University - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 507 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT03337399 record still lists
NCT03337399 is an interventional study that assigns participants to a tested intervention. The registered 507 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (46% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Stepped PC is the first listed.
NCT03337399 reports a single indexed study location in Massachusetts, North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03337399 about?
NCT03337399 is a clinical study titled "Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung Cancer". This research study is evaluating ways to provide palliative care to patients who have recently been diagnosed with lung cancer
What is the current status of trial NCT03337399?
This trial is currently completed. It is a NA study. The enrollment target is 507 participants. The study started on 2018-02-01. Estimated completion is 2023-12-31.
What conditions does trial NCT03337399 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT03337399?
The interventions under investigation include: Stepped PC (OTHER), Early Integrated PC (OTHER).
Who is sponsoring clinical trial NCT03337399?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03337399 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03337399's enrollment target sits among peer trials
507 68th of 409 higher than 341 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06164717 · 507 participants · NA
Behavioral and Neural Characteristics of Adaptive Speech Motor Control
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- NCT04692675 · 508 participants · NA
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- NCT07391657 · 508 participants · Phase 3
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI